Oncology may continue be one of the hottest sectors across the pharma sector, but other therapeutic areas are catching up in terms of innovation and investment. While oncology and hematology jointly accounted for about one-third of the new FDA approvals in 2023, investors are increasingly betting on precision medicine, advanced drug delivery systems and the use of…
The shift from manual to machine learning in cell and gene therapy drug discovery
Cell and gene therapy (CGT) manufacturing is rapidly transitioning from scientific curiosity to clinical reality. But the manufacturing complexity of CGTs far outpaces traditional biologics production, presenting a multifaceted challenge that is part scientific, part technological. “The manufacturing process for cell therapies and gene therapies is infinitely more complex than it is for let’s say,…
Viral vector analysis for successful targeting in gene therapy
April 25, 2023 is an important anniversary in the field of genomics. It marks the seventieth anniversary of four scientists — James Watson, Francis Crick, Maurice Wilkins, and Rosalind Franklin — publishing a paper in Nature and proposing the double helix structure of DNA1. The discovery of the double helix with complementary strands helped scientists…